Metronomic chemotherapy (MC) with irinotecan (CPT-11) in patients with diagnosis of metastatic colorectal cancer (MCRC): clinical, pharmacodynamic (PD) and pharmacokinetic (PK) evaluation. Final report
Abstract
Publication Date:
2007
Citation:
Metronomic chemotherapy (MC) with irinotecan (CPT-11) in patients with diagnosis of metastatic colorectal cancer (MCRC): clinical, pharmacodynamic (PD) and pharmacokinetic (PK) evaluation. Final report / B. M. T., G. Bocci, L. F., F. A., B. G., O. P., A. G., M. G., B. C., A. M., C. S., B. S., R. Danesi, A. DI PAOLO, D.T. M., A. Falcone - In: Proceedings 9th National Congress of Medical Oncology (AIOM)[s.l], 2007. (( convegno 9th National Congress of Medical Oncology (AIOM) tenutosi a Palermo, Italy nel 12 - 15 October.
IRIS type:
03 - Contributo in volume
List of contributors:
B. M. T., G. Bocci, L. F., F. A., B. G., O. P., A. G., M. G., B. C., A. M., C. S., B. S., R. Danesi, A. DI PAOLO, D.T. M., A. Falcone
Link to information sheet:
Book title:
Proceedings 9th National Congress of Medical Oncology (AIOM)